VSLRGDTRG
VSLRGDTRG is a synthetic peptide containing the RGD motif from cadherin 17 (CDH17), which binds to α2β1 integrin and activates its signaling pathway. VSLRGDTRG promotes the high-affinity conformational change of β1 integrin through the RGD motif, enhancing cell adhesion and phosphorylation of FAK and ERK1/2, thereby driving tumor proliferation and metastasis. VSLRGDTRG can be used in research on cancers expressing CDH17, such as colon cancer and pancreatic cancer[1][2].
Product Specifications
CAS Number
2027476-29-3
UNSPSC
12352209
Target
ERK; FAK; Integrin
Related Pathways
Cytoskeleton; MAPK/ERK Pathway; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Smiles
CC(C)[C@H](N)C(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(NCC(N[C@@H](CC(O)=O)C(N[C@@H]([C@H](O)C)C(N[C@H](C(NCC(O)=O)=O)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C38H69N15O14
Molecular Weight
960.05
References & Citations
[1]Bartolome R A, et al. An RGD motif present in cadherin 17 induces integrin activation and tumor growth[J]. Journal of Biological Chemistry, 2014, 289 (50) : 34801-34814.|[2]Jose Ignacio CASAL ALVAREZ, et al. Agents binding specifically to human cadherin-17, human cadherin-5, human cadherin-6 and human cadherin-20 rgd motif. Patent, WO2016169581A1, 2016-10-27.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E7710 96 Tests
Lymphoid enhancer-binding Factor 1 (LEF1) Mouse ELISA Kit
Sign In for Pricing
View Details LV718295 1.0 µg DNA
ADH5P3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
MBS9024957-01 100 mg
5-(tert-Butoxycarbonyl)pyridine-3-boronic acid pinacol ester
Sign In for Pricing
View Details MBS9024957-02 5x 100 mg
5-(tert-Butoxycarbonyl)pyridine-3-boronic acid pinacol ester
Sign In for Pricing
View Details